A Systematic Review and Narrative Synthesis of Factors Impacting Late Diagnosis of Chronic Hepatitis B and C. [PDF]
Ibegu M +4 more
europepmc +1 more source
Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update. [PDF]
Lampertico P +3 more
europepmc +1 more source
Indeterminate Phase/Grey Zone of Chronic Hepatitis B: Clinical Features, Outcomes and Molecular Insights. [PDF]
Franzè MS +5 more
europepmc +1 more source
Efficacy and safety of tenofovir amibufenamide in patients with chronic hepatitis B: a real-world clinical study. [PDF]
Fan R, Fan H, Tan L, Zhang J, Ai L.
europepmc +1 more source
Expression and significance of INTS10 and IRF3 in chronic hepatitis B patients. [PDF]
Ye A, Chen X, Qiu D, Wu W.
europepmc +1 more source
Global patterns and trends in kidney cancer incidence and mortality
What's New? Decreasing mortality from kidney cancer in developed countries contrasts with persistently high or rising mortality in less‐developed regions. Factors underlying this widening gap remain incompletely understood. Using GLOBOCAN 2022 data, the present study examined patterns in kidney cancer incidence and mortality worldwide and the relation ...
Anton Barchuk +5 more
wiley +1 more source
Refining surveillance of hepatocellular carcinoma in chronic hepatitis B through biomarker-based risk stratification. [PDF]
Tseng TC, Huang SC, Kao JH.
europepmc +1 more source
What's New? Breast cancer is now the most common malignancy among women in sub‐Saharan Africa (SSA). Its impact on survivors’ quality of life and Global Health Status (GHS), however, remains inadequately studied in this setting. Here, using data from the African Breast Cancer‐Disparities in Outcomes (ABC‐DO) study, the authors examined GHS over time in
Shamsudeen Mohammed +10 more
wiley +1 more source
Unveiling the role of interleukin-13 in liver fibrosis of chronic hepatitis B patients: Development of a predictive model. [PDF]
Bestari MB +4 more
europepmc +1 more source
What's New? Uveal melanoma is the most common primary intraocular cancer in adults, and up to half of patients develop metastatic disease, predominantly in the liver, where prognosis remains poor despite promising treatment options. In this study, the authors evaluated the safety and efficacy of administering systemic therapy within 40 days of liver ...
Patrick Kasteleiner +4 more
wiley +1 more source

